| abstract |
The present invention relates to new substituted quinoline compounds and pharmaceutically acceptable salts, esters or prodrugs thereof, compositions of the new compounds together with pharmaceutically acceptable carriers, and uses of the new compounds as kinesin spindle protein inhibitors. The compounds of the invention have the following general formula (I). |